Purpose
|
An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
|
Characteristics
|
Tradename: RIDAURA Source of Compound: semisynthetic, Target: NF-κB inhibitor Receptor: PRDX5,NF-κB kinase Status: USP
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C20H34AuO9PS
|
Solubility
|
10 mM in DMSO
|